I

Imago BioSciences, Inc.

36 employees

Imago is a clinical stage biopharmaceutical company that develops drugs for the management of proliferative diseases of the bone marrow.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
orphandiseases
Therapeutics
clinicalgenetics
healthcareinforamtion
oncology
Life Science

Date founded

2012

Funding rounds raised

Total raised

$80M

from 12 investors over 12 rounds

I

Imago BioSciences, Inc. raised $80M on November 19, 2020

Investors: Omega Funds, Greenspring Associates, Kingdon Capital Management, Xeraya Capital, Irving Investors, Surveyor Capital and T. Rowe Price

I

Imago BioSciences, Inc. raised $40M on March 21, 2019

Investors: Greenspring Associates, Omega Funds and Frazier Healthcare Partners

I

Imago BioSciences, Inc. raised $27M on October 31, 2014

Investors: Frazier Healthcare Partners and Clarus Ventures, LLC

FAQ